The predicted secondary infection levels following a stable disease-free state match data in the case of EcSf2a-2 OMP, which suggests that some anti-OMP immunity (not necessarily protective) was established by the EcSf2a-2 vaccine. The gene discussed is OMP; the disease is infection.